In the BioHarmony Drug Report Database
Methocarbamol
Robaxin (methocarbamol) is a small molecule pharmaceutical. Methocarbamol was first approved as Robaxin on 1982-01-01. It is used to treat muscle cramp, muscle rigidity, myositis, pain, and spasm amongst others in the USA. It is known to target carbonic anhydrase 1.
Trade Name
|
Robaxin |
---|---|
Common Name
|
methocarbamol |
ChEMBL ID
|
CHEMBL1201117 |
Indication
|
muscle cramp, muscle rigidity, myositis, pain, spasm, tetanus |
Drug Class
|
Image (chem structure or protein)